Identification of Novel miRNA Biomarkers for Epilepsy: A qRT-PCR-Based Profiling Study
Ebru Derici Eker,
No information about this author
Recep Korkulu
No information about this author
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 7, 2025
Abstract
Epilepsy
is
a
widespread
neurological
disorder
affecting
over
70
million
individuals
globally,
with
approximately
4.9
new
cases
diagnosed
annually.
Despite
extensive
research,
the
underlying
mechanisms
of
epilepsy
remain
incompletely
elucidated.
MicroRNAs
(miRNAs)
are
being
increasingly
utilized
as
crucial
biomarkers
in
various
disorders,
and
their
targeting
proteins
involved
disease
pathogenesis
represents
promising
therapeutic
strategy.
This
study
aimed
to
identify
novel
candidate
miRNAs
associated
evaluate
diagnostic
potential.
The
expression
profiles
84
were
analyzed
plasma
samples
from
20
patients
25
controls
using
qRT-PCR
on
BioMarkTM
96.96
Dynamic
Array
(Fluidigm
Corporation)
system.
In
group,
total
44
exhibited
decreased
compared
control
which
24
statistically
significant.
Notably,
18
demonstrated
highly
significant
reduction
levels
(
p<
0.0001).
These
include
hsa-let-7e-5p,
hsa-miR-105-5p,
hsa-miR-106b-5p,
hsa-miR-107,
hsa-miR-125b-5p,
hsa-miR-128,
hsa-miR-135b-5p,
hsa-miR-138-5p,
hsa-miR-152,
hsa-miR-15a-5p,
hsa-miR-193b-3p,
hsa-miR-203a,
hsa-miR-339-5p,
hsa-miR-381-3p,
hsa-miR-409-3p,
hsa-miR-511,
hsa-miR-539-5p,
hsa-miR-7-5p.
40
increased
among
28
23
increase
(
p
<
hsa-miR-101-3p,
hsa-miR-130a-3p,
hsa-miR-132-3p,
hsa-miR-146a-5p,
hsa-miR-146b-5p,
hsa-miR-181a-5p,
hsa-miR-212-3p,
hsa-miR-27a-3p,
hsa-miR-28-5p,
hsa-miR-302b-5p,
hsa-miR-337-3p,
hsa-miR-338-3p,
hsa-miR-34a-5p,
hsa-miR-455-5p,
hsa-miR-485-5p,
hsa-miR-487a,
hsa-miR-499a-5p,
hsa-miR-509-3p,
hsa-miR-512-3p,
hsa-miR-518b,
hsa-miR-652-3p,
hsa-miR-9-3p,
hsa-miR-95.
findings
suggest
that
hold
potential
innovative,
non-invasive
for
early
detection
diagnosis
epilepsy,
offering
avenue
advancing
clinical
practices.
Language: Английский
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
253, P. 155023 - 155023
Published: Dec. 10, 2023
Language: Английский
The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: A review focus on signaling pathways
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
253, P. 155044 - 155044
Published: Dec. 20, 2023
Language: Английский
Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
Harnessing the power of miRNAs: The molecular architects of asthma pathogenesis and potential targets for therapeutic innovation
Pathology - Research and Practice,
Journal Year:
2023,
Volume and Issue:
253, P. 155054 - 155054
Published: Dec. 22, 2023
Language: Английский